Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Quidelortho Corp
(NQ:
QDEL
)
42.61
-1.01 (-2.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Quidelortho Corp
< Previous
1
2
3
4
5
6
7
Next >
Biotech Stocks are Due for a Rally
November 22, 2021
There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.
Via
Talk Markets
Looking for Growth in Small and Mid Cap Life Science Stocks
November 15, 2021
2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps.
Via
Talk Markets
Quidel Corp (QDEL) Q3 2021 Earnings Call Transcript
November 05, 2021
QDEL earnings call for the period ending October 4, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation
November 02, 2021
Quidel Corporation to Sponsor Distinguished Speaker Series Conducted by the Bay Area Lyme Foundation
Via
News Direct
Exposures
COVID-19
Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21
October 18, 2021
Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21
Via
News Direct
Exposures
COVID-19
Product Safety
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
Quidel Blows Past Estimates for Q3 Revenue
October 14, 2021
COVID-19 testing volumes are up again.
Via
The Motley Fool
Exposures
COVID-19
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected
October 08, 2021
Quidel Corporation (NASDAQ: QDEL) announced preliminary estimates for its Q3 revenues are expected to rise between 6% and 7% Y/Y on COVID-19 assay sales. Related:...
Via
Benzinga
Exposures
COVID-19
After the Jobs Report, Investors are Looking at The Fed for Tapering Signals
October 08, 2021
Investors were in wait-and-see mode before the Employment Situation Report and then the volatility hit. Non-farm job growth was expected to be around 500,000...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Data
October 08, 2021
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade ahead of the all-important jobs report for the month of September. Analysts expect nonfarm...
Via
Benzinga
5 Stocks To Watch For October 8, 2021
October 08, 2021
Some of the stocks that may grab investor focus today are: At its annual shareholder meeting, Tesla Inc’s (NASDAQ: TSLA) CEO Elon Musk announced plans to move its...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 07, 2021
Gainers Vaxart (NASDAQ:VXRT) shares incr...
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
Employer Demand For Rapid COVID-19 Tests Deepen Shortage In US: Reuters
October 06, 2021
In recent weeks, an increase in demand for COVID-19 tests from U.S. employers has deepened the shortage of rapid tests and is driving up testing programs costs. What Happened: The...
Via
Benzinga
Exposures
COVID-19
2 Growth Stocks to Buy if You're Worried COVID Is Here to Stay
October 02, 2021
These could be good hedges to help offset the pandemic-related risks.
Via
The Motley Fool
Exposures
COVID-19
Biotech Playbook Revisited As Technicals Weaken
September 27, 2021
Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still...
Via
Talk Markets
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
September 24, 2021
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19...
Via
Benzinga
Exposures
COVID-19
Product Safety
Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market
September 09, 2021
Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.
Via
Talk Markets
Why Shares of Quidel Surged 10% This Week
September 02, 2021
Demand for its COVID tests are rising with cases.
Via
The Motley Fool
Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy
September 02, 2021
Quidel Corporation's (NASDAQ: QDEL) non-prescription QuickVue At-Home OTC COVID-19 Test will be available next week at CVS Pharmacy locations across...
Via
Benzinga
Exposures
COVID-19
10 Stocks For You To Review
September 01, 2021
Here are 10 stocks you asked me to analyze. Some are attractive, some are dangerously overvalued and all of them offer teaching points.
Via
Talk Markets
Return on Capital Employed Insights for Quidel
August 27, 2021
Pulled from Benzinga Pro data Quidel (NASDAQ:QDEL) posted Q2 earnings of $24.33 million, an increase from Q1 of 89.18%. Sales dropped to $176.61 million, a 52.95% decrease between...
Via
Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
Exposures
COVID-19
Product Safety
Healthcare Stocks Hit New Highs but Small Caps Lag
August 23, 2021
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field.
Via
Talk Markets
84 Biggest Movers From Friday
August 09, 2021
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford...
Via
Benzinga
Why Quidel Stock Was Falling on Friday
August 06, 2021
The company's Q2 headline numbers were nowhere near analyst estimates.
Via
The Motley Fool
Topics
Earnings
Exposures
COVID-19
Financial
55 Stocks Moving In Friday's Mid-Day Session
August 06, 2021
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares jumped 29.9% to $4.47 after the company inked an agreement with turnkey mining solutions provider Hertford Advisors Ltd to provide a...
Via
Benzinga
Quidel Stock Falls As Q2 Earnings Miss Street Estimates On Lower COVID-19, Influenza Product Sales
August 06, 2021
Quidel Corporation (NASDAQ: QDEL) reported after the close of the market Thursday that its second-quarter revenues fell 12% Y/Y to $176.6 million, below the consensus...
Via
Benzinga
Topics
Earnings
Exposures
COVID-19
Financial
Quidel Corp (QDEL) Q2 2021 Earnings Call Transcript
August 05, 2021
QDEL earnings call for the period ending July 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.